DE3022681A1 - Verfahren zur herstellung eines reagens, das agglutination bewirkt und direkter agglutinationstest fuer koerperfluessigkeiten - Google Patents

Verfahren zur herstellung eines reagens, das agglutination bewirkt und direkter agglutinationstest fuer koerperfluessigkeiten

Info

Publication number
DE3022681A1
DE3022681A1 DE19803022681 DE3022681A DE3022681A1 DE 3022681 A1 DE3022681 A1 DE 3022681A1 DE 19803022681 DE19803022681 DE 19803022681 DE 3022681 A DE3022681 A DE 3022681A DE 3022681 A1 DE3022681 A1 DE 3022681A1
Authority
DE
Germany
Prior art keywords
antiserum
agglutination
serum
antigens
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19803022681
Other languages
German (de)
English (en)
Other versions
DE3022681C2 (cg-RX-API-DMAC10.html
Inventor
George R Dr Siber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE3022681A1 publication Critical patent/DE3022681A1/de
Application granted granted Critical
Publication of DE3022681C2 publication Critical patent/DE3022681C2/de
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE19803022681 1979-06-19 1980-06-18 Verfahren zur herstellung eines reagens, das agglutination bewirkt und direkter agglutinationstest fuer koerperfluessigkeiten Granted DE3022681A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/050,269 US4310508A (en) 1979-06-19 1979-06-19 Diagnostic test and reagent therefor

Publications (2)

Publication Number Publication Date
DE3022681A1 true DE3022681A1 (de) 1981-01-22
DE3022681C2 DE3022681C2 (cg-RX-API-DMAC10.html) 1992-07-30

Family

ID=21964303

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803022681 Granted DE3022681A1 (de) 1979-06-19 1980-06-18 Verfahren zur herstellung eines reagens, das agglutination bewirkt und direkter agglutinationstest fuer koerperfluessigkeiten

Country Status (16)

Country Link
US (1) US4310508A (cg-RX-API-DMAC10.html)
JP (1) JPS5631648A (cg-RX-API-DMAC10.html)
AU (1) AU538062B2 (cg-RX-API-DMAC10.html)
BE (1) BE883905A (cg-RX-API-DMAC10.html)
CA (1) CA1138331A (cg-RX-API-DMAC10.html)
CH (1) CH646524A5 (cg-RX-API-DMAC10.html)
DE (1) DE3022681A1 (cg-RX-API-DMAC10.html)
DK (1) DK166234C (cg-RX-API-DMAC10.html)
FI (1) FI68468C (cg-RX-API-DMAC10.html)
FR (1) FR2459480B1 (cg-RX-API-DMAC10.html)
GB (1) GB2052059B (cg-RX-API-DMAC10.html)
IT (1) IT1129088B (cg-RX-API-DMAC10.html)
NL (1) NL191323C (cg-RX-API-DMAC10.html)
NO (1) NO153910C (cg-RX-API-DMAC10.html)
SE (1) SE448577B (cg-RX-API-DMAC10.html)
ZA (1) ZA803473B (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3206729A1 (de) * 1982-02-25 1983-09-01 Behringwerke Ag, 3550 Marburg Immunologisches agglutinationsverfahren
US4403042A (en) * 1982-08-19 1983-09-06 Miles Laboratories, Inc. Detection of cell membrane antigens and corresponding antibodies
JPS5992353A (ja) * 1982-11-19 1984-05-28 Shinotesuto Kenkyusho:Kk 不溶性担体粒子を用いる凝集反応測定方法
JPS60256057A (ja) * 1984-06-01 1985-12-17 Dai Ichi Pure Chem Co Ltd 免疫学的測定法
JPS63106561A (ja) * 1986-05-31 1988-05-11 Toshiba Corp 免疫分析試薬
DE3715333A1 (de) * 1987-05-08 1988-11-24 Behringwerke Ag Verfahren zur quantitativen bestimmung von serumproteinen in koerperfluessigkeiten und mittel zur durchfuehrung des verfahrens
US4921809A (en) * 1987-09-29 1990-05-01 Findley Adhesives, Inc. Polymer coated solid matrices and use in immunoassays
ATE92633T1 (de) * 1988-05-11 1993-08-15 Abbott Lab Verfahren zur erhoehung der spezifizitaet in kompetitiven immuntests.
JPH0354466A (ja) * 1989-07-21 1991-03-08 Sekisui Chem Co Ltd 免疫学的測定試薬及び測定方法
JPH0354465A (ja) * 1989-07-21 1991-03-08 Sekisui Chem Co Ltd 免疫学的測定用希釈液
US5817525A (en) * 1995-05-19 1998-10-06 Chiron Diagnostics Corporation Stable protein solutions for diagnostics and method of making and using the same
US6927071B2 (en) * 2001-12-07 2005-08-09 Beckman Coulter, Inc. Method for reducing non-specific aggregation of latex microparticles in the presence of serum or plasma
US20060190188A1 (en) * 2005-01-25 2006-08-24 Nauta Jozef J Methods and systems for determining lot consistency
CA2552596A1 (en) * 2005-08-09 2007-02-09 Solvay Pharmaceuticals B.V. Methods and systems for determining mid-value titers

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3600494A (en) * 1967-11-06 1971-08-17 Fujizokiseiyaku Kk Serological test for syphilis
DE2134928A1 (de) * 1970-07-17 1972-01-27 Wellcome Found Biologisches Reagens

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1078939A (en) * 1964-08-12 1967-08-09 Pfizer & Co C Diagnostic reagent
US3873683A (en) * 1968-12-10 1975-03-25 Princeton Lab Inc Pregnancy test composition and method
GB1340180A (en) * 1969-12-18 1973-12-12 Kowa Co Process for the preparation of diagnostic agents for primary hepatoma
US3992517A (en) * 1975-02-19 1976-11-16 Pfizer Inc. Detection of hepatitis B surface antigen by latex agglutination
DE2546166A1 (de) * 1975-10-15 1977-04-28 Behringwerke Ag Gegerbte thrombozyten
GB2005275B (en) * 1977-09-19 1982-03-10 Hoffmann La Roche Immunological reagent
JPS5552945U (cg-RX-API-DMAC10.html) * 1978-10-05 1980-04-09

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3600494A (en) * 1967-11-06 1971-08-17 Fujizokiseiyaku Kk Serological test for syphilis
DE2134928A1 (de) * 1970-07-17 1972-01-27 Wellcome Found Biologisches Reagens

Also Published As

Publication number Publication date
NL8003542A (nl) 1980-12-23
FR2459480A1 (fr) 1981-01-09
US4310508A (en) 1982-01-12
FR2459480B1 (fr) 1985-01-11
JPS5631648A (en) 1981-03-31
IT1129088B (it) 1986-06-04
SE448577B (sv) 1987-03-02
NL191323B (nl) 1994-12-16
BE883905A (fr) 1980-12-19
NO801830L (no) 1980-12-22
AU538062B2 (en) 1984-07-26
CH646524A5 (fr) 1984-11-30
AU5940280A (en) 1981-01-08
ZA803473B (en) 1981-09-30
NO153910B (no) 1986-03-03
DK166234B (da) 1993-03-22
GB2052059B (en) 1983-11-30
FI801870A7 (fi) 1980-12-20
CA1138331A (en) 1982-12-28
NO153910C (no) 1986-06-11
SE8004542L (sv) 1980-12-20
IT8067909A0 (it) 1980-06-11
FI68468C (fi) 1985-09-10
DE3022681C2 (cg-RX-API-DMAC10.html) 1992-07-30
GB2052059A (en) 1981-01-21
FI68468B (fi) 1985-05-31
NL191323C (nl) 1995-05-16
DK258080A (da) 1980-12-20
JPH0256633B2 (cg-RX-API-DMAC10.html) 1990-11-30
DK166234C (da) 1993-08-16

Similar Documents

Publication Publication Date Title
DE2902676C2 (de) Verfahren zur Analyse eines von RF oder C1q verschiedenen Antigens im Serum mittels eines Immunoassays
DE69328273T2 (de) Verfahren zur Messung von glykosiliertem Hämoglobin
DE3136579C2 (cg-RX-API-DMAC10.html)
DE3650513T2 (de) Verzögerter immunologischer Test in fester Phase
DE69126248T2 (de) Immunchromatographischer assay und verfahren zur nutzung desselben
CH630465A5 (de) Verfahren zum nachweis oder zur bestimmung eines antikoerper/antigen-komplexes in einer fluidprobe.
DE69718094T2 (de) Verfahren und Kit zur Messung von Hämoglobin A1c
DE69332138T2 (de) Bestimmung von glykosyliertem hämoglobin durch dämpfung der fluoreszenz
DE2633877A1 (de) Verfahren zur immunpruefung auf antigene in fester phase
DE3022681A1 (de) Verfahren zur herstellung eines reagens, das agglutination bewirkt und direkter agglutinationstest fuer koerperfluessigkeiten
DD202178A5 (de) Verfahren und reagens zur untersuchung von antigen-antikoerper-reaktionen
DE3021208C2 (de) Verfahren zur Bestimmung eines Antigens, Antikörpers oder Antigen-Antikörperkomplexes und Verwendung eines in einer Verpackungseinheit konfektionierten Mittels zur Durchführung des Verfahrens
DE2322562C2 (de) Verfahren zur Bestimmung von Antigenen in einer Probe
EP0001223A2 (de) Mit einer Polyhydroxyverbindung beschichteten Latex, Verfahren zur Herstellung dieses Latex, immunologisches Reagenz enthaltend diesen Latex, Verfahren zur Herstellung dieses Reagenzes, Verwendung dieses Reagenzes, Bestimmungsverfahren unter Verwendung dieses Reagenzes und Reagenziengarnitur enthaltend dieses Reagenz.
DE1598898A1 (de) Reagenz und Verfahren zur Bestimmung des Rheumatoidfaktors
DE3105555C2 (cg-RX-API-DMAC10.html)
DE69211805T2 (de) Testsatz und Verfahren zum Nachweiss von Mikroorganismen assoziiert mit periodontalen Krankheiten unter Verwendung Surfactantmischung als Extraktionskomposition
DE2850950C3 (de) Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meßreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren
DE2754350A1 (de) Verfahren zur bestimmung von antikoerpern, antigenen oder komplexen aus antikoerpern und antigenen in fluessigkeiten
CH645727A5 (de) Praeparat zur bestimmung von menschlichem beta-2-mikroglobulin, verfahren zu seiner herstellung und seine verwendung.
DE68926479T2 (de) Testverfahren für antigene oder antikörper
DE68907365T2 (de) Verfahren zur Bestimmung des Vorhandenseins leichter Ketten in Urinproben, Komplex von Vorbereitungen zur Erledigung des Verfahrens und damit verbundenes Reagenz.
DE2725594C2 (de) Verfahren zur Bestimmung der Konzentration freier Schilddrüsenhormone in Flüssigkeiten, insbesondere Blutseren
DE3883808T2 (de) Testsatz, Extraktionsvorrichtung und Verfahren zur Bestimmung von Streptococcus-A-Antigen.
EP0554657B1 (de) Verfahren zur Bestimmung von Antigenen oder Antikörpern in Gegenwart eines Immunkomplexes

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee